The prognosis of breast cancer in males a report of 335 cases
CancerPublished 1 January 1993
Vincent F. Guinee, Rick Shallenberger, Håkan Olsson, Henrik Møller, J. W. van den Blink, Zoltán Péter
Citations162
SJR quartileQ1
SJR score2.95
SNIP1.90
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
No studies of male patients with breast cancer have presented survival information based on the number of histologically positive axillary nodes, the most sensitive single indicator of prognosis in women with breastcancer.
Abstract
The findings of the authors indicate the following: (1) The number of histologically positive axillary nodes and, to a lesser degree, tumor diameter are significant prognostic factors for breast cancer in male patients. (2) The prognosis of breast cancer is the same in male and female patients when compared on the basis of the number of histologically positive nodes.
Keywords
MedicineBiochemistry, Genetics and Molecular Biology
Journal of the Royal Statistical Society Series B (Statistical Methodology)Regression Models and Life-Tables
39,259 Citations1972D. R. Cox
Statistics in MedicineFlexible regression models with cubic splines
2,696 Citations1989Sylvain Durrleman, Richard Simon
CancerRelation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
2,282 Citations1989Christine L. Carter, Carol Allen +1 more
The results of the analyses suggest that disease progression to distant sites does not occur exclusively via the axillary lymph nodes, but rather that lymph node status serves as an indicator of the tumor's ability to spread.
The LancetSystemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
2,189 Citations1992Early Breast Cancer Trialist's Collaborative Group
CancerRelation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update
1,035 Citations1983Bernard Fisher, Madeline Bauer +12 more
Results reveal that there is a risk in combining all patients with ≫4 positive nodes into a single group, and it is concluded that nodal status still remains the primary prognostic discriminant.
Recent results in cancer research/Recent Results in Cancer ResearchSystemic Treatment of Early Breast Cancer by Hormonal, Cytotoxic, or Immune Therapy:133 Randomised Trials involoving 31 000 Recurrences and 24 000 Deaths Among 75 000 Women (Summary)
965 Citations1993Richárd Pető, R. Peto
In a worldwide collaboration, information was sought and centrally checked on mortality and recurrence for each woman in any randomised trial that began before 1985 of any aspect of systemic adjuvant therapy for early breast cancer.
Computer Programs in BiomedicineA computer program for comparing K samples with right-censored data
717 Citations1972Elisa T. Lee, M. M. Desu
CancerManagement and survival of female breast cancer: Results of a national survey by the American college of surgeons
669 Citations1980Takuma Nemoto, J Vána +4 more
In blacks, breast cancer was diagnosed in a relatively more advanced stage than in whites, and survival and cure rates were generally lower for blacks, and such lower rates seem to be associated with the relatively advanced stage of the disease.
CancerPatterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patients
456 Citations1978Pinuccia Valagussa, Gianni Bonadonna +1 more
The records of 716 consecutive patients with breast cancer randomized from January 1964 to January 1968 between radical and extended radical mastectomy not followed by postoperative radiation therapy were reviewed with the intent to define, on clinical basis, the high‐risk groups in whom systemic adjuvant treatment can be attempted.
JAMACancer: Principles and Practice of Oncology
409 Citations1990Walter G. Gunn
The third edition of DeVita, Hellman, and Rosenberg's by now classic text on cancer preserves the multimodal, integrated approach to clinical evaluation and treatment of that disease.
Annals of SurgerySurgical Adjuvant Chemotherapy in Cancer of the Breast
372 Citations1968Bernard Fisher, Robert G. Ravdin +4 more
PubMedTen year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.
368 Citations1975Bernard Fisher, N.H. Slack +2 more
That systemic chemotherapy can enhance the disease-free state as well as survival rate of at least some patients with carcinoma of the breast is supported by the finding that the original observation indicating an advantage for premenopausal women with more than or equal to four positive nodes who received triethylenethiophosphoramide persisted for as long as ten years.
Annals of SurgeryMale Breast Cancer
203 Citations1978Keith S. Heller, Paul Peter Rosen +3 more
Comparison with a series of 304 women with breast cancer operated on at Memorial Hospital in 1960 revealed no difference with regard to incidence of positive axillary lymph nodes or stage of disease, there was, however, a significantly lower survival rate for men.
CancerPathologic findings from the national surgical adjuvant breast project (protocol no. 4).V. significance of axillary nodal micro- and macrometastases
185 Citations1978Edwin R. Fisher, Alka Palekar +3 more
Two‐hundred seventy eight of 565 patients treated by radical mastectomy for invasive breast cancer in a prospective, randomized clinical trial exhibited axillary nodal metastases, suggesting metastases ≥1.3 mm may exert an influence independent of number of nodes involved.
British Journal of CancerMale breast carcinoma--a review of 301 cases from the Christie Hospital & Holt Radium Institute, Manchester
119 Citations1985G Ribeiro
A series of 301 cases of male breast carcinoma has been analysed and patients treated at The Christie Hospital, Manchester and followed-up for a maximum of 15 years have a corrected survival of 55% at 5 years compared to 28% previously.
Surgical Clinics of North AmericaMale Breast Cancer
115 Citations1990Robert W. Crichlow, Spencer W. Galt
Radiation therapy should be strongly considered in patients with metastases to the axillary nodes, but the role of adjuvant hormonal therapy or chemotherapy is unclear and tamoxifen seems to be replacing orchiectomy for treatment of disseminated disease.
Journal of Clinical OncologyMale breast cancer: a 13-year review of 89 patients.
108 Citations1984Charles Erlichman, Kay Murphy +1 more
The results of this review would suggest that many similarities exist between breast cancer in women and in men, and it is reasonable to recommend management of this disease be based on the greater base of knowledge available for carcinoma of the female breast.
CancerCarcinoma of the male breast
94 Citations1969Henry J. Norris, Herbert B. Taylor
On the basis of size, smaller mammary cancers had only a slightly greater frequency of axillary metastasis in men than women but had considerably greater lethality, presumably because of higher frequency of internal mammary lymph node metastasis.
CancerMale breast cancer.A natural history study
80 Citations1979H. Y. Yap, Charles K. Tashima +2 more
Tumori JournalMale Breast Carcinoma: Review of a Multicenter Series of 150 Cases
67 Citations1990Stefano Ciatto, Anna Iossa +18 more
This study suggests that male breast cancer has a worse prognosis with respect to female breast cancer and provides no complete explanation of this finding, except for an intrinsic higher aggressivity.
International Journal of Radiation Oncology*Biology*PhysicsTreatment of curable carcinoma of the breast
65 Citations1977C. D. Haagensen
There is much solid evidence that surgical removal is the most successful method of curing breast cancer in an operable stage, but great confusion has recently developed regarding the extent of the surgical attack required.
Archives of SurgeryCarcinoma of the Male Breast
64 Citations1973William L. Donegan
Men appeared to be no less curable than women when treated with radical mastectomy for comparable stages of the disease and with advanced disease frequently benefited by hormone and endocrine manipulation and one had an unprecedented response to androgen therapy.
PubMedPrognostic factors of carcinoma of the male breast.
54 Citations1984Kenneth Ouriel, M T Lotze +1 more
It appears that the prognosis for male patients with carcinoma of the breast is good if the appropriate therapy is undertaken at an early stage.
CancerCancer of the breast in philadelphia hospitals 1951-1964
53 Citations1969J S Mausner, Michael B. Shimkin +2 more
A registry for cancer of the breast maintained by the Philadelphia County Medical Society from 1951 through 1964 enrolled 9003 patients, and several histologic subtypes, particularly the colloid, intraductal, and lobular carcinomas, showed an advantage in 5‐year survival.
British journal of surgeryA retrospective study of male breast cancer in Holland
51 Citations1985A.N. van Geel, E. A. van Slooten +2 more
Comparison of results from this series, with those of women of the same age having breast cancer, leads to the conclusion that the prognosis in male breast cancer is no worse than for women with comparable disease.
PubMedStaging of breast cancer and survival rates. An assessment based on 50 years of experience with radical mastectomy.
51 Citations1982Donald Ferguson, Paul Meier +4 more
CA A Cancer Journal for CliniciansCancer of the breast in men
50 Citations1991William L. Donegan
The lessons learned from treatment of women are also applicable to men, and in comparable stages men prove equally curable, according to all indications.
CancerLong-term survival following cancer of the male breast in Northern Ireland. A report of 81 cases
50 Citations1985Ray A. J. Spence, Gilbert MacKenzie +3 more
Overall 5‐and 10‐year survival allowing for all causes of death was 38% and 17%, respectively and Cox's (1972) proportional hazard regression model was used to assess the contribution of various factors to survival.
British Journal of CancerMale Breast Cancer
49 Citations1974Ole Scheike
Comparison of the 5-year corrected survival rates in series of male and female breast cancer shows that the prognosis in male breast cancer is not much worse than the prediction in females and it is recommended that treatment of this rather uncommon disease be centralized as far as possible.
World Journal of SurgeryBreast cancer in the male: A report of 138 cases
45 Citations1980G Ramantanis, S Besbeas +1 more
This is a report of 138 male patients with cancer of the breast who were treated at the Hellenic Anticancer Institute from 1937 to 1974, finding that there were no 5-year survivors among patients treated with a combination of radiotherapy, chemotherapy, and hormonal manipulation.
Acta OncologicaMale Breast Carcinoma: II. A study of the total material reported to the Swedish Cancer Registry 1958--1967 with respect to treatment, prognostic factors and survival
35 Citations1987Ragnar Hultborn, Sten Friberg +3 more
The material gave some indications that orchiectomy might prolong survival in patients with recurrent or generalized disease and Radical mastectomy seemed, however, to give fewer loco-regional recurrences than both modified radical mastectomy and simple mastectomy.
Acta OncologicaMale Breast Carcinoma I. A study of the total material reported to the Swedish Cancer Registry 1958-1967 with respect to clinical and histopathologic parameters
33 Citations1987Ragnar Hultborn, Sten Friberg +1 more
The breast cancer incidence rate in males did not increase significantly during the period under review, and the age-specific incidence rate did not show a Clemmesen's hook but increased relatively more rapidly at high ages than for female breast carcinoma.
British journal of surgeryCarcinoma of the male breast: A report of 19 cases and a review of the literature
20 Citations1952Philip Somerville
Only definite prolapses of the disk were recognized in this series and one may perhaps wonder whether the scarred, hidden, or occult disk prolapse may in later years receive no more attention than does the thickened ligamentum flavum to-day, although the latter was once held to explain many of those cases with indefinite findings at operation.
JAMAStaging of breast cancer and survival rates. An assessment based on 50 years of experience with radical mastectomy
11 Citations1982D. J. Ferguson
CancerCombination chemotherapy with vincristine and methotrexate for advanced refractory breast cancer
10 Citations1979Hwee‐Yong Yap, George R. Blumenschein +4 more
Eighteen patients with advanced breast cancer refractory to combination chemotherapy with 5‐FU, Adriamycin, Cytoxan (FAC) were treated with methotrexate 30 to 40 mg/m2 iv and vincristine 1.5 mg/ m2 iv at weekly intervals, achieving partial remission.